Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benfo-C is a fixed-dose combination capsule developed and marketed by Charan Laboratories. It contains benfotiamine (a fat-soluble vitamin B1 derivative), alpha-lipoic acid (an antioxidant), methylcobalamin (vitamin B12), pyridoxine (vitamin B6), and folic acid (vitamin B9). Benfo-C is primarily indicated for the relief of joint pain, muscle pain, and diabetic neuropathy. The combination works synergistically to reduce oxidative stress, support nerve conduction, and promote neuronal regeneration and metabolic health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-lipoic acid + benfotiamine + folic acid + methylcobalamin + pyridoxine.